Aardvark Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -5 | -87 | ||
EBITDA | -15,848 | -10,470 | -9,450 | -5,004 |
EBIT | -15,848 | -10,475 | -9,458 | -5,091 |
Net Income | -14,367 | -9,310 | -8,779 | -4,182 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -9,935 | -11,388 | -7,733 | -3,960 |
Cash | 25,998 | 26,504 | 61,641 | 82,277 |
Basic Shares | 21,690 | 13,194 | 12,909 | 12,909 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -16 | -97 | -110 |
EBITDA | -20,572 | -7,318 | -10,253 |
EBIT | -20,588 | -7,415 | -10,363 |
Net Income | -20,588 | -7,208 | -13,564 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -18,196 | -5,824 | -10,543 |
Cash | 61,641 | 9,735 | 15,559 |
Basic Shares | 12,909 | 12,909 | 9,732 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.66 |
2025-03-31 | -$0.71 |
